HEALWELL AI Reports Q1-2024 Financial Results globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, Dec. 21, 2020 /PRNewswire/ Mind Medicine (MindMed) Inc. (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ) (
MindMed or the
Company ) is pleased to announce that further to its previously announced offering (the
Offering ) on December 14 and December 15, 2020, it has filed a preliminary short form prospectus (the
Preliminary Prospectus ) with the securities commissions or similar authorities in each province of Canada, other than Québec. Pursuant to the underwriting agreement among the Company, Canaccord Genuity Corp. (the
Growing Medical Support Helps Buoy Psychedelic Research
FinancialBuzz.com News Commentary
Share this article
Share this article
NEW YORK, Dec. 14, 2020 /PRNewswire/ There is a plethora of innovations that scientists and researchers have accomplished in biotechnology in recent years. Among the popular fields of study for biotech companies are gene editing, tissue engineering and regeneration, nanobiotechnology and others. In addition, new segments under the biotech umbrella are constantly being developed. For example, the medical cannabis segment has rapidly emerged in recent years, and the continuously growing acceptance of psychedelic drugs is further evidence. According to recent
studies by a number of universities and research institutions, data indicates the usefulness of potential applications of psilocybin. It is a naturally occurring substance that is being examined for the potential use in the treatment of psychiatric conditions. Currently, psychedelics have been use
MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m
Post-Financing Cash Reserves of CAD $85m to Enable Advancement of Digital Therapeutics Division and Growing Clinical Trial Pipeline NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES – Mind Medicine Inc. is pleased to announce that it has closed its previously announced bought deal short form prospectus offering, including the exercise in full of the underwriter’s … Post-Financing Cash Reserves of CAD $85m (USD $66.4m ) to Enable Advancement of Digital Therapeutics Division and Growing Clinical Trial Pipeline NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES